Jusselle

From WikiMD's WELLNESSPEDIA

Jusselle Syndrome
Synonyms N/A
Pronounce N/A
Specialty N/A
Symptoms Developmental delay, Intellectual disability, Facial dysmorphism
Complications N/A
Onset Congenital
Duration Lifelong
Types N/A
Causes Genetic mutation
Risks N/A
Diagnosis Genetic testing
Differential diagnosis N/A
Prevention N/A
Treatment Supportive care
Medication N/A
Prognosis Variable
Frequency N/A
Deaths N/A


Jusselle Syndrome is a rare genetic disorder characterized by a combination of developmental delay, intellectual disability, and distinct facial dysmorphism. The condition is congenital, meaning it is present from birth, and is caused by a genetic mutation.

Signs and Symptoms[edit]

Individuals with Jusselle Syndrome typically exhibit developmental delay and intellectual disability. The degree of intellectual disability can vary among affected individuals. Distinctive facial dysmorphism is also a common feature, which may include microcephaly, hypertelorism, and epicanthal folds.

Causes[edit]

Jusselle Syndrome is caused by a genetic mutation that affects normal development. The specific gene or genes involved in the syndrome have not been fully identified, but it is believed to be inherited in an autosomal dominant pattern.

Diagnosis[edit]

Diagnosis of Jusselle Syndrome is primarily based on clinical evaluation and genetic testing. Genetic testing can confirm the presence of the mutation associated with the syndrome.

Treatment[edit]

There is no cure for Jusselle Syndrome, and treatment is focused on supportive care. This may include physical therapy, occupational therapy, and speech therapy to help manage symptoms and improve quality of life.

Prognosis[edit]

The prognosis for individuals with Jusselle Syndrome is variable and depends on the severity of symptoms. Early intervention and supportive therapies can improve outcomes for affected individuals.

See Also[edit]

References[edit]


External Links[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.